IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lunate Capital Ltd

Q2 2025 Holdings

Filed 2025-07-17 | 6 holdings | $178.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines Inc(RVMD)COM76155X100$80.8M2,196,20045.4%
Sailpoint Inc(SAIL)COM78781J109$68.6M3,000,00038.5%
Lineage Inc(LINE)COM53566V106$26.1M600,00014.7%
Neumora Therapeutics Inc.(NMRA)COM640979100$1.6M2,124,1430.9%
Samsara Inc(IOT)COM CL A79589L106$905.0K22,7510.5%
Revolution Medicines Inc(RVMDW)*W EXP 12/17/20276155X118$118.2K450,0000.1%